|
Sign In to gain access to subscriptions and/or personal tools.
|
Gastrointestinal Complications of Chronic Granulomatous Disease: Case Report and Literature Review
Leslie L. Barton, MD
Department of Pediatrics and The Steele Memorial Children's Research Center; Section of Pediatric Infectious Diseases/3403, University of Arizona Health Sciences Center, 1501 North Campbell Avenue, PO Box 245073, Tucson, AZ 85724-5073
Sosan L. Moussa, MHS, MD
Rodrigo G. Villar, MD
Department of Pediatrics and The Steele Memorial Children's Research Center, Tucson, AZ
Rebecca L. Hulett, MD
The Department of Radiology, The University of Arizona, Tucson, AZ
Chronic granulomatous disease (CGD), an inherited disorder of phagocytic leukocyte function, is characterized by recurrent infections with catalase-positive organisms. Gastrointestinal (GI) tract involvement, present in the majority of affected individuals, may be present initially and recurrently, mimics other entities such as inflammatory bowel disease, and causes substantive morbidity and mortality. Disorders of motility, ulceration, obstruction, and infection (e.g., abscesses) occur from the mouth to the anus and stereotypically manifest with vomiting, diarrhea, abdominal pain, weight loss, and fever. Careful physical examination, in concert with appropriate diagnostic studies, is necessary to delineate intraabdominal pathologic processes. Abdominal radiographs, ultrasonography, computerized tomography, and endoscopy are useful ancillary diagnostic procedures. Drainage of accessible abscesses, antimicrobial therapy based on organisms cultured from blood and tissue, and interferon gamma may lead to suppression or eradication of infections and resolution of symptoms. Corticosteroids are useful for gastric outlet obstruction and sulfasalazine and cyclosporine for large bowel disease. Gallbladder dysfunction may be ameliorated, as in our pa tient, with administration of cholestyramine.
Clinical Pediatrics, Vol. 37, No. 4,
231-236 (1998)
DOI: 10.1177/000992289803700403

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Samarghitean, C. Ortutay, and M. Vihinen
Systematic Classification of Primary Immunodeficiencies Based on Clinical, Pathological, and Laboratory Parameters
J. Immunol.,
December 1, 2009;
183(11):
7569 - 7575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Douvoyiannis, L. Bordy, and E. Fakioglu
An Infant with Diffuse Lung Masses
Clinical Pediatrics,
July 1, 2009;
48(6):
686 - 689.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Johnston Jr and L. L. Barton
Perianal Abscesses
Pediatrics,
February 1, 2008;
121(2):
447 - 447.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev,
January 1, 2007;
87(1):
245 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lukela, D. DeGuzman, S. Weinberger, and S. Saint
Unfashionably Late
N. Engl. J. Med.,
January 6, 2005;
352(1):
64 - 69.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Marciano, S. D. Rosenzweig, D. E. Kleiner, V. L. Anderson, D. N. Darnell, S. Anaya-O'Brien, D. M. Hilligoss, H. L. Malech, J. I. Gallin, and S. M. Holland
Gastrointestinal Involvement in Chronic Granulomatous Disease
Pediatrics,
August 1, 2004;
114(2):
462 - 468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y Moltyaner, W H Geerts, D W Chamberlain, P G Heyworth, D Noack, J Rae, J J Doyle, and G P Downey
Underlying chronic granulomatous disease in a patient with bronchocentric granulomatosis
Thorax,
December 1, 2003;
58(12):
1096 - 1098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Arkwright, M. Abinun, and A. J. Cant
Autoimmunity in human primary immunodeficiency diseases
Blood,
April 15, 2002;
99(8):
2694 - 2702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M G Schäppi, V V Smith, D Goldblatt, K J Lindley, and P J Milla
Colitis in chronic granulomatous disease
Arch. Dis. Child.,
February 1, 2001;
84(2):
147 - 151.
[Abstract]
[Full Text]
|
 |
|
|
|